Literature DB >> 24021515

Impairment of executive function and attention predicts onset of affective disorder in healthy high-risk twins.

Maj Vinberg1, Kamilla W Miskowiak, Lars Vedel Kessing.   

Abstract

OBJECTIVE: To investigate whether measures of cognitive function can predict onset of affective disorder in individuals at heritable risk.
METHOD: In a high-risk study, 234 healthy monozygotic and dizygotic twins with and without a co-twin history of affective disorder (high- and low-risk twins, respectively) were identified through nationwide registers and assessed at baseline using the Schedules for Clinical Assessment in Neuropsychiatry, the 17-item Hamilton Depression Rating Scale (HDRS), and the cognitive tests Trail Making Test Parts A and B, the Stroop test, and the Cambridge Cognitive Examination-Revised (CAMCOR). Participants were followed longitudinally at 6-month intervals for up to 9 years and finally reassessed with a personal interview to obtain information on whether they had developed psychiatric illness. The study was conducted between 2003 and 2012.
RESULTS: 36 participants (15.4%) developed psychiatric disorder, mainly affective and anxiety disorders (31 diagnoses) (ICD-10). Onset was predicted by decreased executive function as reflected by performance on the Trail Making Test A - B (hazard ratio [HR] = 1.02; 95% CI, 1.00-1.03) when adjusted for sex, age, years of education and HDRS score at baseline. Reduced global cognitive function as indicated by a lower CAMCOR score at baseline showed a trend toward an association with subsequent illness onset (P = .08). With regard to the 5 CAMCOR subscales, lower scores on attention (HR = 0.71; 95%, CI, 0.54-0.94) and language (HR = 0.76; 95% CI, 0.58-0.99) were significantly associated with subsequent illness onset.
CONCLUSIONS: Among healthy individuals at heritable risk for affective disorder, discrete cognitive deficits, especially within executive function and attention, seem to predict subsequent onset of affective illness. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24021515     DOI: 10.4088/JCP.12m08258

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Vulnerabilities in sequencing and task switching in healthy youth offspring of parents with mood disorders.

Authors:  Manpreet K Singh; Sara M Leslie; Kalpa Bhattacharjee; Melina Gross; Elizabeth F Weisman; Laila M Soudi; Owen R Phillips; Alexander Onopa
Journal:  J Clin Exp Neuropsychol       Date:  2017-11-23       Impact factor: 2.475

Review 2.  The association between cognitive function and subsequent depression: a systematic review and meta-analysis.

Authors:  M A Scult; A R Paulli; E S Mazure; T E Moffitt; A R Hariri; T J Strauman
Journal:  Psychol Med       Date:  2016-09-14       Impact factor: 7.723

3.  Preschool Executive Function Predicts Childhood Resting-State Functional Connectivity and Attention-Deficit/Hyperactivity Disorder and Depression.

Authors:  Elizabeth J Hawkey; Rebecca Tillman; Joan L Luby; Deanna M Barch
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-07-21

4.  Distinct and Shared Endophenotypes of Neural Substrates in Bipolar and Major Depressive Disorders.

Authors:  Toshio Matsubara; Koji Matsuo; Kenichiro Harada; Masayuki Nakano; Mami Nakashima; Toshio Watanuki; Kazuteru Egashira; Matakazu Furukawa; Naofumi Matsunaga; Yoshifumi Watanabe
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

5.  Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients.

Authors:  Manli Huang; Shaojia Lu; Liang Yu; Lingjiang Li; Peng Zhang; Jianbo Hu; Weihua Zhou; Shaohua Hu; Ning Wei; Jinwen Huang; Jian Weng; Yi Xu
Journal:  BMC Psychiatry       Date:  2017-01-11       Impact factor: 3.630

6.  Risk for affective disorders is associated with greater prefrontal gray matter volumes: A prospective longitudinal study.

Authors:  Julian Macoveanu; William Baaré; Kristoffer H Madsen; Lars Vedel Kessing; Hartwig Roman Siebner; Maj Vinberg
Journal:  Neuroimage Clin       Date:  2017-12-07       Impact factor: 4.881

Review 7.  GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Authors:  Becky Inkster; Gwyneth Zai; Gemma Lewis; Kamilla W Miskowiak
Journal:  Transl Psychiatry       Date:  2018-10-11       Impact factor: 6.222

8.  Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.

Authors:  Jeff Zarp Petersen; Lejla Sjanic Schmidt; Maj Vinberg; Martin Balslev Jørgensen; Ida Hageman; Hannelore Ehrenreich; Gitte Moos Knudsen; Lars Vedel Kessing; Kamilla Woznica Miskowiak
Journal:  Trials       Date:  2018-11-06       Impact factor: 2.279

Review 9.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775

10.  An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study.

Authors:  Bjarke Ebert; Kamilla Miskowiak; Morten Kloster; Jon Johansen; Cara Eckholm; Torbjörn Wærner; Mads Holme; Louise Meldgaard Bruun
Journal:  BMC Psychiatry       Date:  2017-11-21       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.